Related Experiment Video
Updated: May 3, 2026
13:19
Microarray-based Identification of Individual HERV Loci Expression: Application to Biomarker Discovery in Prostate Cancer
Published on: November 2, 2013
19.4K
Biochip analysis of prostate cancer
M Q Fan1, P X Wang1, J Y Feng1
1Department II of Urology, XinQiao Hospital, Third Military Medical University, Chongqing, China.
Genetics and Molecular Research : GMR
|January 22, 2014
Summary
Gene expression analysis can predict prostate cancer progression. Identifying key genes and transcriptional factors (TFs) offers insights into the transition from normal to metastatic prostate cancer.
Area of Science:
- Oncology
- Genomics
- Bioinformatics
Background:
- Prostate cancer progression involves complex genetic changes.
- Understanding gene expression differences is crucial for predicting clinical behavior.
Purpose of the Study:
- To identify differentially co-expressed genes (DCGs) and their roles in prostate cancer pathogenesis.
- To investigate the relationship between transcriptional factors (TFs) and target genes in primary and metastatic prostate cancer.
Main Methods:
- Microarray expression analysis was employed to identify DCGs.
- Regulatory impact factors were calculated to assess TF influence.
- Gene expression data was analyzed to differentiate between normal, primary, and metastatic prostate cancer stages.
Main Results:
- Identified 5 TFs and 29 target genes associated with the normal to primary prostate cancer transition.
- Identified 2 TFs and 7 target genes associated with the primary to metastatic prostate cancer transition.
- Demonstrated the significance of TF-target gene interactions in prostate cancer metastasis.
Conclusions:
- Gene expression profiling can potentially predict prostate cancer clinical behavior.
- TF-target gene networks are key determinants in prostate cancer progression.
- This study provides a foundation for developing predictive biomarkers for prostate cancer.
